CLAIMEL
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that the CLAIMEL application is dead – it was abandoned on Feb 12 2018 because no Statement of Use was filed after the Notice of Allowance, and the owner listed is Glaxo Group Limited, a private UK company. The only goods covered are pharmaceutical preparations and substances for a very wide range of medical conditions in International Class 005, so a similar name used for drugs, vaccines or related health products would be the closest record‑based concern. The record does not give Glaxo control over every possible use of the word “CLAIMEL” in other industries. This was a Principal Register filing; the prosecution history shows a series of extensions for the required Statement of Use before the final abandonment, but no Supplemental Register entry appears. The latest meaningful event is the abandonment notice on Feb 12 2018, and the supplied history shows no oppositions, cancellations or other enforcement activity. I'd treat this as a meaningful concern if you plan a pharma‑related brand with a similar name.
Informational only - not legal advice.Mark Trademark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Jun 23, 2014 |
| Published for opposition | Nov 11, 2014 |
| Notice of Allowance | Jan 06, 2015 |
| Status date | Feb 12, 2018 |
Goods & services
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner & representation
| Owner | Glaxo Group Limited |
| Address | 980 Great West Road, Brentford, Middlesex UNITED KINGDOM TW89GS |
| Entity | private company limited by shares (prc) - organized in UNITED KINGDOM |
| Attorney of record | Christopher M. Hanes |
| Correspondent | CHRISTOPHER M. HANES |
| Attorney email | t********@*****.com |
| Correspondent email | t********@*****.com |
| Correspondent phone | 9********3 |
| Correspondent address | Research Triangle Park, NORTH |